基本信息
浏览量:79
职业迁徙
个人简介
Mikhail Kolonin is a tenured Professor and the Harry E. Bovay, Jr. Distinguished University Chair in Metabolic Disease at the University of Houston Texas School of Medicine. He received his PhD in molecular medicine from Wayne State University where he pioneered the concept of expressing peptides designed to disrupt protein interactions in animals. As a post-doctoral fellow at M.D. Anderson Cancer Center, he has used screens of combinatorial libraries in mice and cancer patients to identify peptides targeting tissue-specific cell surface protein interactions. As a result, he has identified tissue-specific cell surface markers that have been pursued as drug targets. Dr. Kolonin has invented several experimental therapeutics targeting specific cell populations implicated in obesity and cancer. Current research of his laboratory converges on the multifaceted roles of progenitor cells from fat tissue in maintenance of healthy metabolism and in pathology. Currently, Dr. Kolonin is the Director of the Center for Metabolic and Degenerative Diseases at the Institute for Molecular Medicine.
研究兴趣
论文共 186 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Diabetesno. 5 (2024): 701-712
Cancer Researchno. 6_Supplement (2024): 2957-2957
Joseph Rupert,Alexes Daquinag,Lingyi Cai,Yulin Dai, Zhongming Zhao,Dimitris Anastassiou,Mikhail Kolonin
Cancer Researchno. 6_Supplement (2024): 716-716
Sydney S. Wilbon,Mikhail G. Kolonin
Cancer and Metastasis Reviewsno. 3 (2024): 1-4
加载更多
作者统计
#Papers: 186
#Citation: 10032
H-Index: 47
G-Index: 99
Sociability: 6
Diversity: 3
Activity: 114
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn